Related Experiment Video
Updated: Mar 27, 2026

Chronic Post-Ischemia Pain Model for Complex Regional Pain Syndrome Type-I in Rats
Published on: January 21, 2020
Complex Regional Pain Syndrome-Type 1 Presenting as deQuervain's Stenosing Tenosynovitis
1Ashirvad Institute for Pain Management and Research, Mumbai, India.
Complex Regional Pain Syndrome-1 (CRPS-1) may present as deQuervain
Area of Science:
- Pain Medicine
- Musculoskeletal Disorders
- Rehabilitation Medicine
Background:
- Complex Regional Pain Syndrome-1 (CRPS-1) is a debilitating condition often presenting with chronic pain and disability.
- Differential diagnosis of CRPS-1 can be challenging, with conditions like deQuervain's tenosynovitis (DQST) sometimes mimicking its symptoms.
Observation:
- A case report details a 24-year-old woman with a 3-year history of CRPS-1 whose symptoms were initially misdiagnosed and treated as DQST.
- The patient experienced persistent pain and functional limitations despite conservative and surgical interventions for DQST.
- The underlying issue was identified as CRPS-1 with clinical diagnostic criteria (CDC) stemming from inflammatory tendinosis caused by abnormal agonist/antagonist muscle co-contraction in the digits.
Findings:
- Ultrasound-guided dry needling (USGDN) successfully relaxed the affected muscles, restoring normal agonist/antagonist coordination and resolving the tendinosis.
- This intervention led to the reversal of inflammation, alleviating the CRPS-1 symptoms and associated disability.
- Six months post-treatment, the patient reported significant reductions in pain scores, psychological distress, and upper extremity disability, with normalized musculoskeletal ultrasound findings.
Implications:
- This case suggests that CRPS-1 may originate from abnormal muscle co-contraction leading to tendinosis, mimicking conditions like DQST.
- USGDN emerges as a potential therapeutic strategy for CRPS-1 by addressing the primary muscular imbalance and subsequent inflammation.
- Effective treatment of the underlying tendinosis through USGDN can reverse the inflammatory manifestations and functional disability characteristic of CRPS-1.
More Related Videos
05:18Author Spotlight: Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome
Published on: May 26, 2023
09:39Establishing a Mouse Model of a Pure Small Fiber Neuropathy with the Ultrapotent Agonist of Transient Receptor Potential Vanilloid Type 1
Published on: February 13, 2018
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Regional Terms
Primarily, the human body has two major regions, the axial and appendicular regions. The axial region comprises regions from the head to the abdomen and makes up the central body axis. In contrast,...
Local Anesthetics: Differential Sensitivity of Nerve Fibers
Endocarditis II: Clinical Features of Infective Endocarditis
Pericarditis II: Clinical Features and Diagnostic Tests